1090706
Capecitabine
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 154361-50-9
Synonym(S): 5′-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1090706-200-MG | In Stock | ₹ 40,756.13 |
1090706 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
grade
pharmaceutical primary standard
API family
capecitabine
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
SMILES string
O[C@H]1[C@@H](O)[C@H](N2C(N=C(NC(OCCCCC)=O)C(F)=C2)=O)O[C@@H]1C
InChI
1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1
InChI key
GAGWJHPBXLXJQN-UORFTKCHSA-N
Gene Information
human ... TYMS(7298)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Medchemexpress LLC HY-B0016 500mg , Capecitabine CAS:154361-50-9 Purity:>98% | -- | ₹ 5,139.75 | ||
Medchemexpress LLC HY-B0016 5g , Capecitabine CAS:154361-50-9 Purity:98% | -- | ₹ 18,503.10 | ||
Sigma Aldrich Fine Chemicals Biosciences Capecitabine European Pharmacopoeia (EP) Reference Standard | 154361-50-9 | MFCD00930626 | | -- | ₹ 17,007.90 | ||
Sigma Aldrich Fine Chemicals Biosciences Capecitabine United States Pharmacopeia (USP) Reference Standard | 154361-50-9 | MFCD00930626 | 200MG | -- | ₹ 47,632.80 | ||
Sigma Aldrich Fine Chemicals Biosciences Capecitabine | 154361-50-9 | MFCD00930626 | 10 mg | -- | ₹ 7,039.90 | ||
Sigma Aldrich Fine Chemicals Biosciences Capecitabine | 154361-50-9 | MFCD00930626 | 50 mg | -- | ₹ 21,368.90 | ||
Capecitabine | -- | ₹ 11,864.20 | ||
Capecitabine | -- | ₹ 24,962.45 | ||
Capecitabine | -- | ₹ 14,267.35 | ||
5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine | -- | ₹ 356.00 - ₹ 1,424.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Capecitabine USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.
- Biochem/physiol Actions: Capecitabine is an anti-cancer drug, a prodrug of doxifluridine, metabolized to 5-fluorouracil at the tumor site. The activation of capecitabine follows a pathway with three enzymatic steps and two intermediary metabolites, 5′-Deoxy-5-fluorocytidine (5′-DFCR) and 5′-Deoxy-5-fluorouridine (5′-DFUR), to form 5-fluorouracil.
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Carc. 1B - Muta. 2 - Repr. 1B
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable